The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics.
about
Extraintestinal Pathogenic Escherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the FieldEscherichia coli and Sudden Infant Death SyndromeA new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131Population-based epidemiology and microbiology of community-onset bloodstream infectionsEpidemic potential of Escherichia coli ST131 and Klebsiella pneumoniae ST258: a systematic review and meta-analysisThe role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.Genomic Analysis of Factors Associated with Low Prevalence of Antibiotic Resistance in Extraintestinal Pathogenic Escherichia coli Sequence Type 95 Strains.Fine-Scale Structure Analysis Shows Epidemic Patterns of Clonal Complex 95, a Cosmopolitan Escherichia coli Lineage Responsible for Extraintestinal InfectionCorrelation between the genomic o454-nlpD region polymorphisms, virulence gene equipment and phylogenetic group of extraintestinal Escherichia coli (ExPEC) enables pathotyping irrespective of host, disease and source of isolationGalleria mellonella infection model demonstrates high lethality of ST69 and ST127 uropathogenic E. coli.Escherichia coli ST131, an intriguing clonal groupRapid identification of major Escherichia coli sequence types causing urinary tract and bloodstream infections.Variation in resistance traits, phylogenetic backgrounds, and virulence genotypes among Escherichia coli clinical isolates from adjacent hospital campuses serving distinct patient populations.Metagenomic Sequencing with Strain-Level Resolution Implicates Uropathogenic E. coli in Necrotizing Enterocolitis and Mortality in Preterm Infants"Population structure of drug-susceptible,-resistant and ESBL-producing Escherichia coli from community-acquired urinary tract"Comparative virulence of urinary and bloodstream isolates of extra-intestinal pathogenic Escherichia coli in a Galleria mellonella model.Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections.CIPROFLOXACIN RESISTANCE PATTERN AMONG BACTERIA ISOLATED FROM PATIENTS WITH COMMUNITY-ACQUIRED URINARY TRACT INFECTIONTrends in ExPEC serogroups in the UK and their significance.Escherichia coli sequence type 131: epidemiology and challenges in treatment.Comparative Genomics of Escherichia coli Isolated from Skin and Soft Tissue and Other Extraintestinal InfectionsEscherichia coli sequence type 73 as a cause of community acquired urinary tract infection in men and women in Rio de Janeiro, Brazil.Systematic longitudinal survey of invasive Escherichia coli in England demonstrates a stable population structure only transiently disturbed by the emergence of ST131.Genomic Analysis of Multidrug-Resistant Escherichia coli from North Carolina Community Hospitals: Ongoing Circulation of CTX-M-Producing ST131-H30Rx and ST131-H30R1 Strains.Molecular epidemiology of Escherichia coli sequence type 131 and its H30/H30-Rx subclones recovered from extra-intestinal infections: first report of OXA-48 producing ST131 clone from Iran.High frequency of B2 phylogroup among non-clonally related fecal Escherichia coli isolates from wild boars, including the lineage ST131.Whole-Genome Analysis of Antimicrobial-Resistant and Extraintestinal Pathogenic Escherichia coli in River Water.CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain.Response to Giufre et al.Clonal Diversity, Virulence Potential and Antimicrobial Resistance of Escherichia coli Causing Community Acquired Urinary Tract Infection in Switzerland.Epidemiology and Antimicrobial Resistance Characteristics of the Sequence Type 131-H30 Subclone Among Extraintestinal Escherichia coli Collected From US Children.Impact of host-pathogen-treatment tripartite components on early mortality of patients with Escherichia coli bloodstream infection: Prospective observational study
P2860
Q26786281-158C4B59-FD30-485E-A0BB-7C143C4E0F6DQ26801961-24548A21-492B-408C-93E6-3A53832C6665Q27011287-2DB30550-BB51-4C56-8AAE-0CC139500E93Q27013639-E0DA3749-9E8F-4460-8AB7-AEA5853A3943Q28073332-75CE7A03-9C67-4182-91DC-829F7C57422AQ30300020-EB7363FE-9F37-4BE4-8B6F-BF4B3BFC130DQ30401029-4BF9C64A-D1D8-452E-8BA2-EBC01F17CFEAQ30402837-343B3AC3-5A71-41B6-AD3F-ECD27B8093CDQ30596244-EB30A6DA-2CEB-4474-8F98-1E29510C760AQ33952196-A70C7C51-811B-445C-9AF5-D694C1A97ACAQ34057648-175C22DA-3EC3-4C49-9F2D-52D9C03F12DDQ34916386-E2FCBC30-EDFB-4D05-81CD-0E771C9EEA3FQ35960847-D31491B7-F66B-46FE-B0C3-1FB512763E47Q35964279-A6A49ABE-E354-41F0-BDF7-CECA7654E700Q35986381-B7C04672-F25E-4B4D-BC5D-EA892975FA76Q36147517-AAA2F6E2-A8FF-46A5-9E1C-125778C254CAQ36729974-EEF1A0D6-252E-41D4-9E6D-EF63F6698580Q37134169-C7EB0D63-93A3-4687-BA1B-BC634840BC59Q37280926-2F57E54C-A525-4936-8FAA-1CD475CB8ECEQ38201515-068A0DF7-F51B-4E25-A8A6-F978600C57DDQ38623188-030E69D4-DF7A-4EFB-9D8F-004C30C01EBAQ38954151-84079EA9-369E-4E3C-80D9-5C821DCC829FQ39116648-11956284-ECEE-4EC9-9C6D-E5D2B4A001F1Q40171775-5E16BEAA-20E5-4045-BCB3-EBA14DF9CE1FQ40183330-BF0D1D1E-4655-46B0-94FE-3A2A3E2D5AEBQ40269298-03628401-614E-465F-94D2-B66146952BF0Q40406138-B95E4A09-992A-47E6-AEE8-46A7A358B0B4Q40587151-4D39B537-433A-4ECD-8756-799081A74886Q42733585-49B47ADC-AEA2-44D5-B567-1DA98FF333B8Q47106522-830B654D-F281-463D-9B24-01ED5159EC15Q47820247-E6408B2F-DE94-44EB-9A36-523FA9AE8D18Q57210717-CE6A2479-792A-4EF0-A0E2-6F0D8DB089FA
P2860
The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The clonal distribution and di ...... ng to patient characteristics.
@en
The clonal distribution and di ...... ng to patient characteristics.
@nl
type
label
The clonal distribution and di ...... ng to patient characteristics.
@en
The clonal distribution and di ...... ng to patient characteristics.
@nl
prefLabel
The clonal distribution and di ...... ng to patient characteristics.
@en
The clonal distribution and di ...... ng to patient characteristics.
@nl
P2093
P2860
P356
P1476
The clonal distribution and di ...... ng to patient characteristics.
@en
P2093
Brian Johnston
Christine Lohse
Evgeni V Sokurenko
Ritu Banerjee
Sujay Chattopadhyay
Veronika Tchesnokova
P2860
P304
P356
10.1128/AAC.01065-13
P407
P577
2013-09-16T00:00:00Z